Invention Grant
![Method for producing a polymorphic form of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-N-cyclopropyl-4-methylbenzamide](/docs/US/2021-05-04/US10995071B2/abs.jpg.600x600.jpg)
- Patent Title: Method for producing a polymorphic form of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-N-cyclopropyl-4-methylbenzamide
-
Application No.: US16317014Application Date: 2017-07-13
-
Publication No.: US10995071B2Publication Date: 2021-05-04
- Inventor: Osama Suleiman , Lucia Romero Perez , Cornelius Stephan Harlacher , Stewart Jones
- Applicant: MEREO BIOPHARMA 1 LIMITED
- Applicant Address: GB London
- Assignee: MEREO BIOPHARMA 1 LIMITED
- Current Assignee: MEREO BIOPHARMA 1 LIMITED
- Current Assignee Address: GB London
- Agency: Wolff IP, a Prof Corp
- Agent Jessica Wolff
- Priority: GB1612238 20160714
- International Application: PCT/GB2017/052055 WO 20170713
- International Announcement: WO2018/011578 WO 20180118
- Main IPC: C07D231/38
- IPC: C07D231/38
![Method for producing a polymorphic form of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-N-cyclopropyl-4-methylbenzamide](/abs-image/US/2021/05/04/US10995071B2/abs.jpg.150x150.jpg)
Abstract:
This invention relates to a process for the preparation of Form B of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-N-cyclopropyl-4-methylbenzamide. Also disclosed herein is Form B of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-N-cyclopropyl-4-methylbenzamide, or pharmaceutical compositions thereof, obtainable by the process described herein.
Public/Granted literature
Information query
